Trial Profile
Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 10 Feb 2017 New trial record